https://orcid.org/0000-0001-7884-5466
References
- Jayaseelan VP , ArumugamP. Exosomal microRNAs as a promising theragnostic tool for essential hypertension. Hypertens. Res.43(1), 74–75 (2020).
- Jayaseelan VP , ArumugamP. Dissecting the theranostic potential of exosomes in autoimmune disorders. Cell. Mol. Immunol.16(12), 935–936 (2019).
- Jayaseelan VP , ArumugamP. Exosome-derived ncRNAs as potential drivers of epigenetic reprogramming of cancer stem cells. Epigenomics13(18), 1439–1441 (2021).
- Jurgielewicz B , SticeS , YaoY. Therapeutic potential of nucleic acids when combined with extracellular vesicles. Aging Dis.12(6), 1476–1493 (2021).
- Wang Y , GuoM , LinDet al. Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation in vitro and in vivo. Drug Deliv.28(1), 1510–1523 (2021).
- Zhang XF , WangT , WangZXet al. Hypoxic ucMSC-secreted exosomal miR-125b promotes endothelial cell survival and migration during wound healing by targeting TP53INP1. Mol. Ther. Nucleic Acids26, 347–359 (2021).
- Zhou Y , WenLL , LiYFet al. Exosomes derived from bone marrow mesenchymal stem cells protect the injured spinal cord by inhibiting pericyte pyroptosis. Neural Regen. Res.17(1), 194–202 (2022).
- Sun Z , SunD , FengYet al. Exosomal linc-ROR mediates crosstalk between cancer cells and adipocytes to promote tumor growth in pancreatic cancer. Mol. Ther. Nucleic Acids26, 253–268 (2021).
- Liang G , KanS , ZhuY , FengS , FengW , GaoS. Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells. Int. J. Nanomedicine13, 585–599 (2018).
- Liang G , ZhuY , AliDJet al. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J. Nanobiotechnology18(1), 10 (2020).
- Kase Y , UzawaK , WagaiSet al. Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression. Sci. Rep.11(1), 5897 (2021).
- Kumar S , KarmacharyaM , MichaelIJet al. Programmed exosome fusion for energy generation in living cells. Nat. Catal.4, 763–774 (2021).
- Li B , YangJ , WangRet al. Delivery of vascular endothelial growth factor (VEGFC) via engineered exosomes improves lymphedema. Ann. Transl. Med.8(22), 1498 (2020).
- Kim H , KimEH , KwakG , ChiSG , KimSH , YangY. Exosomes: cell-derived nanoplatforms for the delivery of cancer therapeutics. Int. J. Mol. Sci.22(1), 14 (2020).